Geisinger Urology team to host virtual information event about enlarged prostates
The session will offer potential patients the chance to learn more about Aquablation and Rezum. Participants will also have the opportunity to ask questions.
Aquablation therapy, using the power of water jet ablation and robotic precision, can provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of the shape or size of a man’s prostate.
Rezum delivers a targeted, controlled dose of stored thermal energy in water vapor directly to the prostate gland.
The exact cause of enlarged prostates is unknown, but hormonal changes in older men do play a role in the enlargement of the prostate glands blocking the urethra. Patients with enlarged prostates often have frequent urination, blood in the urine, urinary incontinence, and urinary retention.
Registration is open until Nov. 3. Visit geisinger.org/menshealth to secure your spot.
About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across central and northeastern Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates more than $8 billion in annual revenues across 163 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 500 medical professionals annually and is conducting more than 1,400 clinical research studies. With more than 27,000 employees, including 1,800 employed physicians and 5,200 registered nurses, Geisinger is among Pennsylvania’s largest employers, having an estimated economic impact of $16.8 billion on the state’s economy. In 2024, Geisinger joined Risant Health, a nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on Facebook, Instagram and LinkedIn.
